Coherus Oncology Inc (CHRS)

Other Income/Expenses (Net)

-$4.55M

TTM · Period ending: · USD

CHRS logo

CHRS Other Income/Expenses (Net)

Latest reported-$4.55M
CHRS TTM Other Income/Expenses (Net) (-$17.64M → -$4.55M)
High-resolution chart · PNG

CHRS other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Coherus Oncology Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
-4,551,000
-2,911,000
-4,090,000
-12,073,000
-14,153,000
-7,189,000
-5,475,000
-7,773,000
-11,424,000
-27,338,000
-35,073,000
-31,702,000
-29,888,000
-27,699,000
-34,874,000
-33,675,000
-33,215,000
-32,814,000
-23,242,000
-22,729,000
-22,588,000
-21,837,000
-20,613,000
-18,710,000
-17,061,000
-15,951,000
-14,993,000
-13,325,000
-11,228,000
-6,128,000
-4,993,000
-5,502,000
-6,026,000
-6,015,000
-6,150,000
-6,031,000
-4,426,000
-13,076,000
-11,857,000
-9,746,000
-9,241,000
-1,966,000
-4,871,000
-6,961,000
-8,184,000
-15,177,000
-22,495,000
-24,136,000
-37,335,000
-29,628,000
-17,642,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.